Insights into TOR function and rapamycin response: Chemical genomic profiling by using a high-density cell array method
Open Access
- 9 May 2005
- journal article
- research article
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 102 (20) , 7215-7220
Abstract
With the advent of complete genome sequences, large-scale functional analyses are generating new excitement in biology and medicine. To facilitate genomewide functional analyses, we developed a high-density cell array with quantitative and automated readout of cell fitness. Able to print at >×10 higher density on a standard microtiter plate area than currently possible, our cell array allows single-plate screening of the complete set of Saccharomyces cerevisiae gene-deletion library and significantly reduces the amount of small molecules and other materials needed for the study. We used this method to map the relation between genes and cell fitness in response to rapamycin, a medically important natural product that targets the eukaryotic kinase Tor. We discuss the implications for pharmacogenomics and the uncharted complexity in genotype-dependent drug response in molecularly targeted therapies. Our analysis leads to several basic findings, including a class of gene deletions that confer better fitness in the presence of rapamycin. This result provides insights into possible therapeutic uses of rapamycin/CCI-779 in the treatment of neurodegenerative diseases (including Alzheimer's, Parkinson's, and Huntington's diseases), and cautions the possible existence of similar rapamycin-enhanceable mutations in cancer. It is well established in yeast that although TOR2 has a unique rapamycin-insensitive function, TOR1 and TOR2 are interchangeable in the rapamycin-sensitive functions. We show that even the rapamycin-sensitive functions are distinct between TOR1 and TOR2 and map the functional difference to a ≈120-aa region at the N termini of the proteins. Finally, we discuss using cell-based genomic pattern recognition in designing electronic or optical biosensors.Keywords
This publication has 42 references indexed in Scilit:
- Regulation of Lifespan in Drosophila by Modulation of Genes in the TOR Signaling PathwayCurrent Biology, 2004
- Development of Small Molecule Hsp90 Inhibitors: Utilizing Both Forward and Reverse Chemical Genomics for Drug IdentificationCurrent Medicinal Chemistry, 2003
- Optical imaging fiber-based live bacterial cell array biosensorAnalytical Biochemistry, 2003
- TOR signalling in bugs, brain and brawnNature Reviews Molecular Cell Biology, 2003
- A genome-wide screen for methyl methanesulfonate-sensitive mutants reveals genes required for S phase progression in the presence of DNA damageProceedings of the National Academy of Sciences, 2002
- Large-scale mutagenesis and functional genomics in yeastFunctional & Integrative Genomics, 2002
- Enhancement of the Antifungal Activity of Rapamycin by the Coproduced Elaiophylin and Nigericin.The Journal of Antibiotics, 2000
- Genomic profiling of drug sensitivities via induced haploinsufficiencyNature Genetics, 1999
- Molecular evidence for an ancient duplication of the entire yeast genomeNature, 1997
- TOR kinase domains are required for two distinct functions, only one of which is inhibited by rapamycinCell, 1995